Gavi had been expecting Novavax deliveries to begin as soon as summer 2021, but the company bungled its vaccine production. As a consequence, Gavi did not proceed with placing the orders for the ...

The Gavi agreement covered the purchase of 350 million vaccine doses. By mid-November 2022, Gavi had only ordered about 2 million doses, Novavax said. The company sent Gavi a termination notice.

In June of 2021, Clover and Gavi signed on to their partnership, with the company agreeing to provide up to 414 million doses of SCB-2019, its protein-based COVID shot, through 2022. But like ...

The company cited Gavi's failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility. The termination has not resulted in any penalties, ...

Novavax has agreed to pay back international vaccine group Gavi at least $475 million in cash or vaccines by the end of 2028, settling a dispute over canceled orders that created financial ...

Global vaccine alliance Gavi on Tuesday rejected Novavax's claim that the group had breached an advance purchase agreement to procure 350 million doses of the company's COVID-19 vaccine.

Global vaccine alliance Gavi said on Tuesday it was not in breach of a deal to buy Novavax's COVID-19 vaccine and that it reserved all rights, including the recovery of advance payments to the ...

Gavi said in a statement Thursday that its “utmost concern ... this is just not a very smart thing to do,” Offit said. RFK Jr ...

As for Novavax’s end of the bargain, the company has already made an initial payment of $75 million to Gavi and will ultimately hand over up to $400 million in installments of $80 million each ...